Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Mar
8
2024
IP Challenges in the Energy Transition [Podcast] Foley & Lardner LLP
Apr
4
2024
Peter Rabbit Discovers Compliance! Foley & Lardner LLP
Feb
4
2020
Patent Portfolios of the Top 25 Well-Funded AV Companies Foley & Lardner LLP
May
20
2024
Driving Tomorrow’s Advances in the Health Care and Life Sciences Ecosystems [Video] Foley & Lardner LLP
Jun
30
2016
Patent Infringement: Pennsylvania Court Invalidates Improper Multiple Dependent Claims Foley & Lardner LLP
May
11
2020
New USPTO Pilot Program to Expedite Grant of Small Entity COVID-19 Patents Foley & Lardner LLP
Oct
3
2016
Spokeo and "No-Injury" Class Actions in Wisconsin Courts Foley & Lardner LLP
Nov
22
2016
Thanksgiving Patent Special: Turkey In Every Patent Foley & Lardner LLP
Oct
19
2020
Stealing Home: The Quiet Game of Trade Secret Theft in the Telework Economy Foley & Lardner LLP
Jun
12
2017
Supreme Court Decision Largely Favors Biosimilar Applicants Foley & Lardner LLP
May
11
2021
New USPTO COVID-19 Initiatives Foley & Lardner LLP
Jul
6
2021
Mind Your Examples Foley & Lardner LLP
Aug
2
2021
Supreme Court Limits Patent Assignor Estoppel Foley & Lardner LLP
Mar
10
2015
The Remicade Biosimilar Patent Dispute Foley & Lardner LLP
Dec
13
2021
USPTO To Propose Paperless Patents Foley & Lardner LLP
Dec
20
2021
A December to Remember: The Trademark Modernization Act Implemented on December 18, 2021 Foley & Lardner LLP
Sep
11
2017
SELF DRIVE Act Passes the House as Senate Prepares Its Own Bill Foley & Lardner LLP
May
9
2022
USPTO Proposes To Require Electronic PTE Applications Foley & Lardner LLP
Jun
16
2022
Key Intellectual Property Considerations for Joint or Outside Development Projects Foley & Lardner LLP
Jul
21
2015
DNA Sequencing Patents: Simultaneous Invention As Secondary Evidence Of Obviousness Foley & Lardner LLP
Jan
9
2018
Prosecution History Informs Claim Meaning Even Without Unmistakable Disclaimer Foley & Lardner LLP
Aug
18
2022
Using Upfront IP Licensing to Reduce Future Supply Chain Disruptions Foley & Lardner LLP
Jan
23
2018
Three Things To Know About Rule 130 Declarations Foley & Lardner LLP
Sep
14
2022
Exception to the Rule? Late Submission of Evidence as Supplemental Information Under 37 C.F.R. 42.123(b) Foley & Lardner LLP
Feb
20
2018
Are These INOMax Therapeutic Method Claims Directed To A Natural Phenomenon? Foley & Lardner LLP
Oct
20
2022
Common Diligence Issues for Startup and Emerging Technology Companies Foley & Lardner LLP
Apr
16
2018
Federal Circuit Upholds Vanda Fanapt Personalized Method Claims Against Patent Eligibility Challenge Foley & Lardner LLP
May
15
2018
Claim Construction Of An Enantiomeric Chemical Structure Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins